BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 1500018)

  • 1. A clinicopathological study of 30 melanomas of the vulva.
    Tasseron EW; van der Esch EP; Hart AA; Brutel de la Rivière G; Aartsen EJ
    Gynecol Oncol; 1992 Aug; 46(2):170-5. PubMed ID: 1500018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis of treatment and prognosis of 59 cases of vulvar melanoma].
    Yuan GW; Li XG; Li N; Yao HW; Wu LY
    Zhonghua Fu Chan Ke Za Zhi; 2020 Jun; 55(6):395-401. PubMed ID: 32842246
    [No Abstract]   [Full Text] [Related]  

  • 3. Prognostic indicators in melanoma of the vulva.
    Raspagliesi F; Ditto A; Paladini D; Fontanelli R; Stefanon B; Dipalma S; De Palo G
    Ann Surg Oncol; 2000 Dec; 7(10):738-42. PubMed ID: 11129421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melanomas of the vulva and vagina.
    Trimble EL
    Oncology (Williston Park); 1996 Jul; 10(7):1017-23; discussion 1024. PubMed ID: 8837119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Results of an individualized surgical therapy of vulvar carcinoma from 1973-1993].
    Köhler U; Schöne M; Pawlowitsch T
    Zentralbl Gynakol; 1997; 119 Suppl 1():8-16. PubMed ID: 9245126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vulvar melanoma reconsidered.
    Look KY; Roth LM; Sutton GP
    Cancer; 1993 Jul; 72(1):143-6. PubMed ID: 8508398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of vulvar melanoma.
    Trimble EL; Lewis JL; Williams LL; Curtin JP; Chapman D; Woodruff JM; Rubin SC; Hoskins WJ
    Gynecol Oncol; 1992 Jun; 45(3):254-8. PubMed ID: 1612500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic variables in the treatment of squamous cell carcinoma of the vulva.
    Shimm DS; Fuller AF; Orlow EL; Dosoretz DE; Aristizabal SA
    Gynecol Oncol; 1986 Jul; 24(3):343-58. PubMed ID: 3721307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant melanoma of the vulva.
    Jaramillo BA; Ganjei P; Averette HE; Sevin BU; Lovecchio JL
    Obstet Gynecol; 1985 Sep; 66(3):398-401. PubMed ID: 4022497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conservative therapy for melanoma of the vulva.
    Rose PG; Piver MS; Tsukada Y; Lau T
    Am J Obstet Gynecol; 1988 Jul; 159(1):52-5. PubMed ID: 3394753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors in early vulvar cancer.
    Rowley KC; Gallion HH; Donaldson ES; van Nagell JR; Higgins RV; Powell DE; Kryscio RJ; Pavlik EJ
    Gynecol Oncol; 1988 Sep; 31(1):43-9. PubMed ID: 3410354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radical vulvectomy and inguinal lymphadenectomy versus inguino-pelvic lymphadenectomy combined with radical vulvectomy and the role of radiotherapy.
    Lanza A; Valli M; Caldarola B; D'Addato F; Re A; Boidi Trotti A; Beccaris M; Ferraris G
    Eur J Gynaecol Oncol; 1988; 9(1):67-73. PubMed ID: 3345788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant melanoma of the vulva. Evaluation of prognostic factors with emphasis on DNA ploidy in 75 patients.
    Scheistrøen M; Tropé C; Koern J; Pettersen EO; Abeler VM; Kristensen GB
    Cancer; 1995 Jan; 75(1):72-80. PubMed ID: 7804980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant melanoma of the vulva: A report of 44 cases.
    Chung AF; Woodruff JM; Lewis JL
    Obstet Gynecol; 1975 Jun; 45(6):638-46. PubMed ID: 1143724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of lymph node status and number of removed nodes in patients with squamous cell carcinoma of the vulva treated with modified radical vulvectomy and inguinal-femoral lymphadenectomy.
    Gadducci A; Ferrero A; Tana R; Fabrini MG; Modaffari P; Fanucchi A; Vignati C; Zola P
    Eur J Gynaecol Oncol; 2012; 33(6):640-3. PubMed ID: 23327062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant melanoma of the vulva.
    Bastable JH; Gompel C; Verhest A
    Diagn Gynecol Obstet; 1980; 2(1):55-62. PubMed ID: 7472144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T2/3 vulva cancer: a case-control study of triple incision versus en bloc radical vulvectomy and inguinal lymphadenectomy.
    Siller BS; Alvarez RD; Conner WD; McCullough CH; Kilgore LC; Partridge EE; Austin JM
    Gynecol Oncol; 1995 Jun; 57(3):335-9. PubMed ID: 7774837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical therapy of T1 and T2 vulvar carcinoma: further experience with radical wide excision and selective inguinal lymphadenectomy.
    Burke TW; Levenback C; Coleman RL; Morris M; Silva EG; Gershenson DM
    Gynecol Oncol; 1995 May; 57(2):215-20. PubMed ID: 7729737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does T1, N0-1 vulvar cancer treated by vulvectomy but not lymphadenectomy need inguinofemoral radiation?
    Manavi M; Berger A; Kucera E; Vavra N; Kucera H
    Int J Radiat Oncol Biol Phys; 1997 Jul; 38(4):749-53. PubMed ID: 9240642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [PROGNOSTIC MODELS IN MODERN MANAGEMENT OF VULVAR CANCER].
    Tsvetkov Ch; Gorchev G; Tomov S; Nikolova M; Genchev G
    Akush Ginekol (Sofiia); 2016; 55(1):17-26. PubMed ID: 27514127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.